122226-03-3

Basic information

• Product Name: (3S,5S,4'S,5'R)-5-<3'-<(tert-butyloxy)carbonyl>-4'-(cyclohexylmethyl)-2',2'-dimethyloxazolidin-5'-yl>-3-methyldihydrofuran-2(3H)-one
• Synonyms: (3S,5S,4'S,5'R)-5-<3'-<(tert-butyloxy)carbonyl>-4'-(cyclohexylmethyl)-2',2'-dimethyloxazolidin-5'-yl>-3-methyldihydrofuran-2(3H)-one
• CAS NO: 122226-03-3
• Molecular Weight: 395.539
• Mol File: 122226-03-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (3S,5S,4'S,5'R)-5-<3'-<(tert-butyloxy)carbonyl>-4'-(cyclohexylmethyl)-2',2'-dimethyloxazolidin-5'-yl>-3-methyldihydrofuran-2(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: (3S,5S,4'S,5'R)-5-<3'-<(tert-butyloxy)carbonyl>-4'-(cyclohexylmethyl)-2',2'-dimethyloxazolidin-5'-yl>-3-methyldihydrofuran-2(3H)-one(122226-03-3)
• EPA Substance Registry System: (3S,5S,4'S,5'R)-5-<3'-<(tert-butyloxy)carbonyl>-4'-(cyclohexylmethyl)-2',2'-dimethyloxazolidin-5'-yl>-3-methyldihydrofuran-2(3H)-one(122226-03-3)

Safety Data

• Hazardous Substances Data: 122226-03-3(Hazardous Substances Data)

Upstream product

• 117997-58-7 tert-butyl (4S,5R)-4-(cyclohexylmethyl)-5-formyl-2,2-dimethyl-3-oxazolidinecarboxylate 
• 122226-01-1 3-<(tert-butyloxy)carbonyl>-4-(cyclohexylmethyl)-2,2-dimethyl-5-vinyloxazolidine 
• 104856-05-5 (3RS,4S)-4-<(tert-butyloxy)carbonyl>-5-(cyclohexylmethyl)-3-hydroxy-1-pentene 
• 122226-02-2 (5S,4'S,5'R)-5-<3'-<(tert-butyloxy)carbonyl>-4'-(cyclohexylmethyl)-2',2'-dimethyloxazolidin-5'-yl>-3-methylenedihydrofuran-2(4H)-one 

Downstream Products

• 122226-04-4 (4S,5R,1'S,3'S)-3-<(tert-butyloxy)carbonyl>-4-(cyclohexylmethyl)-5-(1'4'-dihydroxy-3'-methylbutyl)-2',2'-dimethyloxazolidine 
• 127230-21-1 Toluene-4-sulfonic acid (2S,4S,5R,6S)-7-cyclohexyl-4,5-dihydroxy-2-methyl-6-(toluene-4-sulfonylamino)-heptyl ester 
• 127230-19-7 (4S,5R)-4-Cyclohexylmethyl-5-((1S,3S)-1-hydroxy-4-methanesulfonyloxy-3-methyl-butyl)-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 122226-05-5 (4S,5R,2'S,4'S)-3-<(tert-butyloxy)carbonyl>-4-(cyclohexylmethyl)-2,2-dimethyl-5-(4'-methyltetrahydrofuran-2'-yl)oxazolidine 
• 127230-20-0 (2S,3R,4S,6S)-1-cyclohexyl-3,4-dihydroxy-6-methyl-2-<(p-tolylsulfonyl)amino>-7-<(p-tolylsulfonyl)oxy>heptane 
• 122226-06-6 (5S,4'S,5'R)-5-<3'-<(tert-butyloxy)carbonyl>-4'-(cyclohexylmethyl)-2',2'-dimethyloxazolidin-5'-yl>-3,3-dimethyldihydrofuran-2(3H)-one 

Relevant articles and documents

Non-peptide renin inhibitors

-

Glaucoma treatment

A method and a composition for treating or reducing and/or controlling intraocular pressure comprising administering an effective amount of a renin inhibiting compound of the formula: STR1 where A is a substituent; W is CO or CHOH and U is CH2 or NR2 wherein R2 is hydrogen or loweralkyl; with the proviso that when W is CHOH then U is Ch2 ; R1 is loweralkyl, cycloalkyl methyl, benzyl, (alpha, alpha)-dimethylbenzyl, 4-hydroxybenzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, 1-bezyloxyethyl, phenethyl, phenoxy, thiophenoxy or anilino; R3 is loweralkyl, loweralkenyl, ((alkoxy)alkoxy)loweralkyl, (thioalkoxy)alkyl, benzyl or heterocyclic ring substituted methyl; and R4 is substituted hydroxyalkyamino.

Potent, Low Molecular Weight Renin Inhibitors Containing a C-Terminal Heterocycle: Hydrogen Bonding at the Active Site

A series of low-nanomolar renin inhibitors containing novel C-terminal heterocycles has been designed by formally cyclizing the C-terminus of a glycol-based inhibitor to the second hydroxyl.Molecular modeling suggests that the heterocyclic oxygen hydrogen